F.L. Putnam Investment Management’s Quest Diagnostics DGX Stock Holding History

F.L. Putnam Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,815	Closed	-$274K	–	572
2024 Q4	$274K	Buy	1,815 +141	+8%	+$21.9K	0.01%	503
2024 Q3	$254K	Buy	1,674 +389	+30%	+$58.1K	﹤0.01%	520
2024 Q2	$176K	Buy	+1,285	New	+$176K	﹤0.01%	539
2023 Q4	–	Sell	-12,785	Closed	-$1.56M	–	486
2023 Q3	$1.56M	Sell	12,785 -13,306	-51%	-$1.77M	0.04%	231
2023 Q2	$3.67M	Buy	+26,091	New	+$3.6M	0.1%	163

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

F.L. Putnam Investment Management's DGX Position: Q1 2025 in Review

F.L. Putnam Investment Management sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 1,815 shares — an estimated $274K sold.

F.L. Putnam Investment Management first reported a position in DGX in Q2 2023 and held it in 5 quarters. The position peaked at $3.67M in Q2 2023. 968 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

F.L. Putnam Investment Management reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
F.L. Putnam Investment Management sold 1,815 Quest Diagnostics shares in Q1 2025, an estimated $274K.
F.L. Putnam Investment Management first reported a position in Quest Diagnostics in Q2 2023 and held it in 5 quarters.
F.L. Putnam Investment Management's Quest Diagnostics position peaked at $3.67M in Q2 2023.
968 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2025, filed 15 May 2025.